PurpleLab builds HealthNexus™, a no‑code analytics platform and RWD infrastructure that helps clients convert real‑world data into real‑world evidence. The company emphasizes proprietary methodologies for data organization, cleansing, management, governance, and deidentification via tokenization. PurpleLab serves life sciences, payers, providers and other healthcare stakeholders seeking faster insights and cost efficiencies. The firm reports triple‑digit growth for four consecutive years and was awarded Qualified Entity certification by CMS. Founded in 2017 and based in Wayne, Pa., PurpleLab positions its product to address increased access to RWD driven in part by mandates such as the 21st Century Cures Act. The company plans to use new funding to accelerate investments in new data assets, product development, and human capital. PurpleLab offers a cloud-based provider analytics platform that models and measures episodes of care using medical and prescription claims data. The company provides self-service, on-demand subscription access to customizable query and report templates designed to profile and rank providers based on quantitative performance metrics. Its analytics cover 1.8 million healthcare providers nationwide. PurpleLab sells to health plans, healthcare providers, and life sciences organizations. Led by founder and CEO Mark Brosso, the company plans to use new capital to further scale its technology and accelerate sales and marketing. In August 2019 PurpleLab raised $3M in growth financing from Edison Partners to support those efforts.

Total raised

$43M

Funding rounds

2

Latest round

Series B

Latest activity

Sep 2022